TCOYD SPONSOR HIGHLIGHT

Xeris Biopharma, the maker of Gvoke HypoPen®, is dedicated to unlocking the potential of glucagon. We believe that easier-to-use medicines can have a profound impact on the lives of patients and their families. That is why our first products to market are liquid glucagon, but that is just the beginning. We are also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue advancements that have the potential to change lives.

INFORMATIVE ARTICLES

Holiday Blood Sugars: Planning for the Unplanned
“The Holidays and Blood Sugars: Planning for the Unplanned”
READ ARTICLE
“Educate Your Inner Circle on Hypoglycemia: It Could Save Your Life!”
READ ARTICLE
“Expect the Unexpected When It Comes to Severe Hypoglycemia in T2D”
READ ARTICLE
“Treating a Low: When to Consume Sugar & When to Use Glucagon”
READ ARTICLE
“A Renaissance in Glucagon: Ready to Use, Ready to Have!”
READ ARTICLE